Injecto Polymers Ltd. IPO: price band, issue size, dates, business profile, financials, and risks

Injecto Polymers Ltd. is launching an SME IPO of ₹56.12 crore in a price band of ₹98 to ₹100 per share. The issue is entirely a fresh issue (no offer for sale), meaning the proceeds are intended to accrue to the company (net of issue expenses). The IPO opened on 11 September 2026 and closed on 16 September 2026, with listing scheduled for 21 September 2026. The lot size is 1,200 shares.

IPO structure, timeline, and category allocation

Injecto Polymers is tapping the SME segment with an issue priced in the ₹98–₹100 band. The timetable provided in the offer documents indicates allotment on 17 September 2026 and refunds on 18 September 2026, ahead of the proposed listing on 21 September 2026.

The issue structure matters because it is fully a fresh issue and has no offer for sale (OFS). Fresh issue proceeds are proposed to be used for company objectives, while OFS proceeds (if any) would have gone to selling shareholders.

For investor categories, the reservation split provided is 50% for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors (NIIs), and 35% for Retail Individual Investors (RIIs). The Red Herring Prospectus (RHP) also lays out the anchor investor framework within the QIB portion, including the anchor portion of the QIB allocation and a domestic mutual fund reservation within the anchor book.

Business overview: products, customers, and operating footprint

Injecto Polymers Limited manufactures plastic packaging products, with a focus on polypropylene (PP) woven fabrics and woven sacks/bags. The stated product range includes biaxially oriented polypropylene (BOPP) laminated bags, flexible intermediate bulk container (FIBC) or jumbo bags, liners, and other related packaging formats. Alongside manufacturing, the company also trades in plastic granules and polyvinyl chloride (PVC) resins.

The business operates primarily on a business-to-business (B2B) model, catering to bulk and customized orders. The end-use exposure described spans agriculture, construction, chemicals, textiles, and consumer-goods users.

On the manufacturing side, the company has two units in West Bengal: one owned unit and one unit operated on a leave-and-license basis from a group company. This operating footprint is relevant to how the company describes its current geographic concentration in eastern India.

Strategy and milestones: capacity expansion and mix shift focus

The RHP outlines a growth strategy centered on scaling the packaging manufacturing business. The stated priorities include expanding installed capacity (including Phase III/IV expansion at Unit I), widening geographic reach beyond the company’s heavy eastern-India concentration, and improving the revenue mix toward manufacturing versus trading.

The milestones disclosed provide context on the company’s operating journey and its public-market readiness. The company was incorporated in 1998 (as a private limited company). In 2015, it acquired land for Manufacturing Unit I at Burdwan, West Bengal. It reported crossing a ₹100 crore revenue turnover milestone in FY2023-24. In FY2024-25, it acquired Manufacturing Unit II at Andul, West Bengal on leave and license, and converted from a private limited to a public limited company.

The company also references high capacity utilization as part of the rationale for raising funds to expand capacity. Post-IPO disclosures on project progress and ramp-up at existing facilities will be central to tracking how the strategy translates into operating outcomes.

Financial trajectory and operating context

Across the three reported financial years in the provided financials, Injecto Polymers has reported higher revenue and profit after tax (PAT) in absolute terms by FY2026 compared with FY2024, alongside a larger asset base. The reported PAT margin for FY2026 is 4.26%. The company also reports an EBITDA margin (earnings before interest, tax, depreciation and amortisation, presented as a margin percentage) of 10.13%.

Within the metrics disclosed alongside the IPO, the company reports return ratios including return on equity (ROE), return on net worth (RoNW), and return on capital employed (ROCE). It also reports a debt-to-equity ratio of 2.61 times, which is relevant given that one of the proposed uses of IPO proceeds is repayment or prepayment of certain borrowings.

The business mix is another operating consideration highlighted in the provided context: the company indicates that over half of revenue comes from trading. Manufacturing-led revenues and trading revenues can carry different working-capital and margin profiles, making the mix an important variable to monitor alongside capacity expansion plans.

Issue proceeds: proposed deployment into debt reduction and Unit I Phase IV capex

Because the IPO is entirely a fresh issue, the company is the intended recipient of the funds raised, net of issue-related expenses. As per the RHP, the net proceeds are proposed to be used for:

Repayment or prepayment (in full or in part) of certain outstanding borrowings availed by the company; capital expenditure for setting up Phase IV at the existing Unit I facility located at NH2 Bypass Road, Jaugram, Abujhabi, Jamlapur, West Bengal 713166; and general corporate purposes.

These are proposed uses rather than completed spending. Execution updates on the Phase IV plan at Unit I and disclosures around the company’s borrowing profile will be key post-issue reference points, especially given the strategy emphasis on capacity addition and shifting the revenue mix toward manufacturing.

Valuation and KPI context, subscription outcome, GMP observations, and key risks

At the upper end of the price band, the IPO metrics provided include a pre-IPO price-to-earnings (P/E) multiple of 9.48 times and a price-to-book multiple of 2.40 times, alongside an earnings per share (EPS) of ₹10.55. The KPI set also includes ROE of 28.94%, ROCE of 15.64%, RoNW of 41.73%, EBITDA margin of 10.13%, and a reported PAT margin of 4.26%.

On subscription, the snapshot indicates total subscription of 0.85 times, with QIBs at 1.02 times, NIIs at 0.80 times, and RIIs at 0.84 times. With the IPO closed and the status marked “listing pending”, the near-term events are the allotment and listing timeline disclosed in the offer schedule.

Grey market premium (GMP) observations provided for 10 dates from 10 September to 19 September 2026 show a GMP of ₹0 against a referenced issue price of ₹100 for each observation. GMP is an unofficial market indicator and can change over time.

Key risks and sensitivities highlighted in the provided context include:

Customer concentration. The company flags that high reliance on top customers can affect revenue and cash flows if a large customer reduces orders or delays payments.

Revenue mix skew toward trading. The context indicates that over half of revenue comes from trading, which can have different volatility and margin characteristics compared with manufacturing.

Geographic concentration. The company highlights its heavy dependence on West Bengal and eastern India for revenues, implying that localized disruptions may affect sales and utilization.

Monitoring points after listing, based on the stated strategy and disclosures:

Phase IV execution at Unit I progresses in line with the stated capex objective, including commissioning and ramp-up.

Manufacturing revenues expand relative to trading revenues, consistent with the company’s stated mix-improvement focus.

Customer concentration reduces over time through additions of accounts and broader order dispersion.

Geographic reach expands beyond the current eastern-India concentration, aligning with the company’s stated intent to widen its footprint.

Complete numeric snapshot

IPO terms and schedule

Key performance indicators and valuation

Category reservations and anchor allocation

Proposed use of fresh issue proceeds

Subscription status (19 Sep 2026)

Grey market premium (GMP) trend

GMP is an unofficial market indicator and can change; these are dated snapshot observations, not a listing forecast.